how quickly could a biopharmaceutical firm produce enough for use in africa. it's experimental. couldn't the ministries require procedures for informed consent from the people who get it. >> i read that it's a complex delivery, this that it arrives frozen, it had to be thawed, thawed slowly, there was a real process for the two individuals for whom it's been used. >> exactly. this is not a little capsule you take. providing fresh, frozen plasma in the united states is standard operating procedure in our community hospitals. not so in africa, much more complex. >> there is also the issue of quarantine. a lot of concern has been expressed, but it seems that there are facilities not only at emory and atlanta, but other places in the country where quarantine units are established, ready, prepared. >> i'm happy to say that any community hospital, academic medical center such as ours, is well-trained in infection control. we have isolation rooms, we have taken care of other people in the normal course of business who have communicable diseases, who know how to do this. in case someone

incyte's vision is to become a leading biopharmaceutical company focused on improving the lives of patientsmedical needs. additional funding provided by: abbott. ironwood pharmaceuticals. janssen pharmaceuticals inc. and by w.l. gore and associates. >> mcfarland: nearly 50,000 people die each year from all types of aortic disease, more than breast cancer or aids or even motor vehicle accidents. but despite this large number, many people have never heard of thoracic or abdominal aortic aneurysms, and therefore they have no idea how to recognize the signs that a potentially life-threatening rupture may be about to occur. >> kind of lucky, isn't it? [laughs] >> yes. >> mcfarland: dr. michel makaroun is professor of surgery and the chair of vascular surgery at university of pittsburgh medical center. >> the aorta is a very large blood vessel. this is the main blood vessel that comes out of the heart and distributes the blood to all the organs. >> mcfarland: the aorta is called the thoracic aorta as it leaves the heart, ascends, arches, and descends through the chest until it reaches the diaphra

. >> it was manufactured by a biopharmaceutical company in san diego. never tested on human but in a desperate effort to save their lives sources tell us they took it and it worked within minutes. dramatic improvement in brantly health strong enough to walk out of this ambulance and into the hospital this weekend. >> the hearing he recovered and he's doing better is terrific news. >>reporter: but experts stress there is no proven cure for ebola. doctors deciding both americans have a better chance at surviving if the symptoms are treated here in the u.s. rather than west africa where the outbreak still surging out of control. experts saying their confident though the disease will not spread here are. >> know what they are doing. it's safe. people should be at ease bit. >>reporter: now about she's expected here tomorrow afternoon like brantly treated in especially isolated room away from other patients. this is abc news atlanta. >> bit more on the experimental ebola drug. it was manufactured by a san diego biopharmaceutical company called map. company we

the reason you're talking to me and not the people at malpractice biopharmaceuticals because they're trying to make as much as they can so they can get into the trial phase. it takes time. >> that's what we want to hear is that they are stepping on the gas if you will. 2015 seems like awfully long way away considering the fact that the numbers increase by the day, the people sickened, dying, it spread to nigeria. confirmed cases and deaths there. it is a concern. one last quick thing, what does a tobacco plant have to do with all of this? >> people are like how does this figure and other are saying this is a good yus for tobacco plant. a lot of these researchers don't have the big budgets, don't have the money to do this, not a big huge biopharmaceutical company so to create more of the antibodies they need a carrier basically and what they're able to do is insert the virus into a tobacco plant, plant starts to die, able to harvest through a multistep process, don't want to bore you, harvest the antibodies out of that and create the serum they're able to put to the ebola virus to era

it was manufactured by a biopharmaceutical company in san diego. never tested on human but in a desperate effort to save their lives sources tell us they took it and it worked. within minutes. leading to dramatic improvement in brantly health living him strong enough to walk out of this ambulance and in the hospital this weekend. >> hearing that he recovered and doing better is terrific news. >>reporter: experts stays there is no proven cure for ebola. doctors both americans have chance of survival if the symptoms are treated here in the u.s. rather than africa where it's surging out of control. they are confident the disease will in the spread here. >> they know what they are doing. it's sale. people should be at ease about it. >> now ripe nancy is expected here tomorrow afternoon and treat entered especially isolated room from other patients. >> like tahoe while lived care will treat a bear cub burned in washington state wildfire. 6 month old cub named cinders. who paw so injured they gave the if sippeder now in the south like tahoe and the team

other fames in technology are also doing well, net app, other names in biopharmaceutical, jazz pharmaceuticalsgrowth there with the pe multiple somewhat suppressed going out a couple months. >> how do you look for this reach at growth in the market run? >> you know water interesting to me, it seems that people are willing to pay for growth. celgene and gilead, not only are they trading at a multiple based on forward earnings, these are companies that have a long track record of earnings and revenue growth. you compare that to gopro or tesla. tesla has yet to prove itself. this is a situation where obviously they're going to sell a respectable number of cars. if you take a look at those multiples, say you you need a million dollars of revenue per cars sold, that's a lot win compare it to other businesses in the space, biotech, that's not true. you can take a look at these companies, versus old health care companies, leak johnson & johnson, these are cheaper. >> we are for the cushion on gilead, we are taking a look at biotech, will is also a potential for consolidation, which has moved a lot of

it was manufactured by a biopharmaceutical company in san diego. never tested on human but in a desperate effort to save their lives sources tell us they took it and it worked. within minutes. leading to dramatic improvement in brantly health living him strong enough to walk out of this ambulance and in the hospital this weekend. >> hearing that he recovered and doing better is terrific news. >>reporter: experts stays there is no proven cure for ebola. doctors both americans have chance of survival if the symptoms are treated here in the u.s. rather than africa where it's surging out of control. they are confident the disease will in the spread here. >> they know what they are doing. it's sale. people should be at ease about it. >> now ripe nancy is expected here tomorrow afternoon and treat entered especially isolated room from other patients. >> like tahoe while lived care will treat a bear cub burned in washington state wildfire. 6 month old cub named cinders. who paw so injured they gave the if sippeder now in the south like tahoe and the team

san diego-based map biopharmaceutical is working to develop a drug to treat the disease. the drug has never been tested for safety in humans. >>> south bay prosecutors have just announced a number of arrests in an investment scam that cost victims their life savings. the santa clara county district attorney said four suspects are behind bars and investigators are searching for a fifth suspect. they are accused of offering huge profits of 50% to 80% to invest in companies that it turned out were just empty storefronts. 17 victims have been identified. mostly from san jose and los angeles. authorities say the suspects targeted undocumented immigrants because they were unlikely to report the crimes. >>> authorities in the north bay are warning residents about a man who may be pretend be to be an officer. last month a known gang member was pulled over in his retired crown victoria police car by sonoma county sheriff's deputies. inside, authorities found a complete kit of law enforcement tools such as a scanner, handcuffs, badge, flashlight. even crime scene tape. deputies hav

other names in technology are also doing well, names like net app, other names in biopharmaceutical, jazz pharmaceutical. growth there with the pe multiple is somewhat suppressed when you look outgoing a couple of months. >> mike, how do you look at the reach for growth where we are in the context of the market run? >> you know what's interesting to me, people are willing to pay for growth in the areas that are not proven. names like gilead, they are companies that have a long track record of earnings and revenue growth. you compare that to something like go pro or you compare it to something like tesla, tesla has yet to prove itself. this is a situation where obviously they're going to sell a respectable number of cars, but if you take a look at those multiples, saying you need a million dollars of enterprise value per car sold, that's a lot compared it other businesses in the space. biotech, that's not true. these companies, growth companies, versus old state health care companies like johnson & johnson, these are actually cheaper. >> right. mike, we're focusing on gilead tonight.

dose of a special serum known as zmapp created by a san diego-based research firm called map biopharmaceuticalhe serum contains antibodies that prevent the virus from entering cells in the body. >> there were very, very few doses and apparently the company is trying to scale up. it's not easy to scale up to very large numbers of doses, but that's something under intense discussion now. >> reporter: while zmapp has not been tested on humans it has shown promising results in monkeys. three precious vials of the medicine scored at subzero temperatures were flown to liberia last week and administered to both dr. brantly and fellow missionary worker nancy writebol who was also infected. soon after the doctor was given the drug his condition improved dramatically doctors say. >> we really need to be careful. i do hope it was as impressive as being described because if it is, that bodes very well for that particular product. >> reporter: tonight dr. brantly remains in this state of the art isolation unit receiving round the clock care. he wife visited him yesterday, but they can't have physical conta

it was manufactured by a biopharmaceutical company in san diego.ver tested on human but in a desperate effort to save their lives sources tell us they took it and it worked. within minutes. leading to dramatic improvement in brantly health living him strong enough tothisof this ambulance and in the hospital this weekend. >> hearing that he recovered and doing better is terrific news. >>reporter: experts stays there is no proven cure for ebola. doctors both americans have chance of survival if the symptoms are treated here in the u.s. rather than africa where it's surging out of control. they are confident the disease will in the spread here. >> they know what they are doing. it's sale. people should be at ease about it. >> now ripe nancy is expected here tomorrow afternoon and treat entered especially isolated room from other patients. >> like tahoe while lived care will treat a bear cub burned in washington state wildfire. 6 month old cub named cinders. who paw so injured they gave the if sippeder now in the south like tahoe and the team says she'

the defense threat reduction agency actually increased funding to this particular biopharmaceutical firm of promising results and whether it had to do with dr. brantley or not, we don't know, but there are discussions to see if this could be made more widely available. we've had no treatments, vak sins seens, no medicines for ebola. >> a medical marvel really. i also want to talk about the fact, in some regions in west africa there's no trust in medical experts and people coming into the village. there's very little trusts that they have in medical officials. that's another look at the story. >> 36 minutes past the hour. ahead for us, another murder suspect found dead after being featured on cnn's "the hunt" -- we'll have that story next. car insurance rates ompag at progressive.com. is that where they show the other guys' rates, too? mm-hmm. cool. yeah. hi. final boarding call for flight 294. [ bells ring on sign ] [ vehicle beeping ] who's ready for the garlic festival? this guy! bringing our competitors' rates to you -- now, that's progressive. that's why i always choose the fastest i

i know the secret serum story about the biopharmaceutical drugs, used on the liberian medical perm, has been aggrav e aggravating to some people down there. they don't like it called secret serum, because it leaves the impression on less educated that america has the solution, that they are sitting on the virus, leading them to think wild conspiracy theories. >> you came back. >> it's for that reason - you came back - i was forced by my school to leave. a couple of weeks before, me and some administrators were talking on the phone and they were "tell us why we shouldn't pull you out." i said i felt safe in free town. people were coming in from up country. we were washing our hands, wearing gloves. we said we feel confident that we'll let you stay. i had to give them daily updates, where i was eating and going. in the end it didn't matter. school administrators pulled me out. they were worried that the disease was spreading faster than it could be detained, and worried about british airlines cancelling their service and worried about others. pre-emptive measure to get me out. >> we follo

"the wall street journal" reported today the drug maker, mapp biopharmaceutical, has now distributed all of the doses it had. that leaves as apparently the main option for officials throughout west africa: stepping up awareness campaigns and screening measures to quarantine the virus. several states: ivory coast, gambia and zambia, have now banned all flights from ebola- infected countries. >> woodruff: given those problems with the health systems and a lack of drugs, what more can be done, and should be done? we ask two people watching this all very closely. lawrence gostin is professor of global health law at georgetown law and the director of the world health organization's center on public health law and jonathan moreno is professor of medical ethics and health policy at university of pennsylvania's perelman school of medicine we welcome you both to the "newshour". there is some late breaking information that's come out. i'll start with you dr. gostin. canadian officials say they have about 1500 doses of a vaccine that can be used on ebola. what do we know about this and can it b

there is a privately held company map biopharmaceuticals, there are reports that its drug was showing signs or promise. it showed competitors like tekmura down in trading. some analysts contend with the current six, investors should proceed with caution when it comes to these types of truck companies. >> it is unclear whether these therapies will get used, will get commercialized and whether or not any of these companies request actually profit off the buy risk in africa, where there is obviously not a large amount of money to pay for theerps. so, again, high risk situation here with these plays, so one would need to be extremely cautious. >> now, speaking of caution, that's also the approach that many health care professionals are taking as well as on the ground in west africa and, okay, here. that should help ease concerns about possible spreading of that ebola. >> we have very strict protocols. those protocols are established before these patients arrive, while they're here and then even after the resolution of their infection. we are going to have all these protocols all set from

charles river provides universities and biopharmaceutical firms with everything they need to discoverrugs, conduct trials, club the lab rats and mice that any potential drug needs to be tested on. companies tools makes the whole process both faster and more efficient, and of course cheaper, which is why biotech and pharma companies are increasely outsourcing the work to charles river and others like it. rallied last year. we had faith it was on fire. then from the first week of april through the first week of may it dropped from 61 down to 50 and spent the next three months stuck in the low 50s, in part because of worries that drug companies were shifting resource budgets away from the early stage toward firms that specialize in later-stain trials. . crl off an 812 basis with higher than expected revenues. they did make an acquisition there. management raised the full-year guidance, so this stock with a 50% gain 20 months allege ready to resume the long march higher? let's take a look with the president and more about where it's headed. welcome back to "mad money." good to see you in

they were given a special serum known as z max, made by a san diego based firm called mapp biopharmaceutical. it prevents the virus from entering cells in the body. it is producing promising effects on the second ebola account, dr. brantley. >> we all assume that he was going to be rolled out on a gurney, but to see him walk, absolutely, renewed sense of energy, and hope. >> three vials of the experimental medicine were flown to liberia and given to both patients before they arrived in the united states. >> a general is dead after an insider attack on a base in afghanistan. mark albert reports he becomes the highest ranking u.s. officer killed in combat since 1970. >> reporter: major general harold green was with nato troops at this base and a man in an afghan army uniform opened fire with a machine gun from the window of a building. green was deputy chief of training and making a site visit to the camp, west of the afghan capital, kabul. it has a military academy. the major general is the highest ranking u.s. service member killed since 9/11. as many as 15 other americans and coalition sold

it was manufactured by a biopharmaceutical company in san diego. in a desperate effort to save their lives, sources tell us they took it and it works within minutes leading to a dramatic improvement in brantly's health leaving him strong enough to walk out of this ambulance and into the hospital this weekend. but experts stress there is no proven cure for ebola. doctors deciding both americans have a better chance at survival if their symptoms are treated here in the u.s. rather than west africa where the outbreak is still surging out of control. >> they know what they're doing. it's safe. people should be at ease about it. >> reporter: like brantly she will be treated in a especially isolated room away from other patients. marci gonzalez, abc news, atlanta. >> let's continue our coverage with dan child, managing editor of abc's medical unit. dan, thank you for joining us. >> thank you. >> good to have you here. both dr. nancy writebol and dr. kent brantly took the experimental drug and appear to be improving. what's in the drug? how do we know it

the serum is being tested in west africa to aid in outbreak but map biopharmaceuticals says the amount requested by west african officials has exhausted its supply. >>> u.s. missionaries working in ebola infected parts of africa are back in north carolina. christian aid agency says its missionaries who lived in liberia are showing no signs of the virus but they will remain in quarantine for three weeks. health workers say this is the worst ebola outbreak responsible for a thousand deaths in three african countries. >>> 6:33. research is confirming what many of us already knew. there is real power in music. >> from the rocky theme to multiple hip hop anthems we all have songs that get us moving. research now shows certain types of music works bester than others and can actually benefit our behavior and even make us feel more powerful. >> researchers at northwestern university decided to take a closer look at the connection between music and the feeling of power. 7500 graduates from the university were tested with 31 different musical selections. genres included everything from heavy met

. >> number nine, mankind -- the biopharmaceutical companies was rated a new buy at jefferies.up more than 3.5% in the premarket and have surged more than 35% so far this year. kind of a cool name. i would pay attention. >> number eight, my mother-in-law's favorite retailer, cheetos. .hey -- chico's they fell short on revenue and sales are down as a result. >> surge in the premarket -- michael's. offeredt estimates and an upbeat forecast. >> my grandmother's favorite store. tivo. six is they beat analyst estimates by a penny they gaining subscribers. they also plan to buy that $350 million worth of stock, but the wellaker forecast profit below analyst estimates, which is sending shares lower in the premarket. >> number five, time warner cable -- customers across the u.s. will up to no internet access this morning and took to vent their frustrations. how did they take to twitter? i guess mobile devices. service has largely been restored. they are in a study -- investigating the source of the problem. it shows how addicted we are. >> i love how people wake up, and something kisse

recently, biopharmaceutical company came to see me, last week, from the boston area. i asked about the acquisitions in the boston area biopharma companies. 28 companies have been acquired in the last several years. 17 of those 28 were acquired by foreign entities. you sort of put the hole in the dam here and you have a flood over here. you have a worse result, even more pressure, on jobs leaving this country. so i mean we talk a lot about revenue and income-stripping and earnings stripping. i agree when you have a tax code that captures income in the most efficient way, but this is about jobs. my question, i guess, to mr. stack is, you know, what's going to happen if we continue to make it harder to be an american company. aren't we going to see more, not just acquisitions, but acquisitions of american assets? they tell me because foreign companies have higher after-tax profits, it's more profitable for them. they can pay a premium for our assets for subsidiaries being sold. you'll see american companies shrinking if not being taken over by foreign entities. what's yo